Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alaunos Therapeutics (TCRT) Short-term Investments (2022 - 2023)

Alaunos Therapeutics (TCRT) has disclosed Short-term Investments for 2 consecutive years, with $13.9 million as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, Short-term Investments changed N/A year-over-year to $13.9 million, compared with a TTM value of $13.9 million through Mar 2023, changed N/A, and an annual FY2022 reading of $13.9 million, changed N/A over the prior year.
  • Short-term Investments was $13.9 million for Q1 2023 at Alaunos Therapeutics, roughly flat from $13.9 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $13.9 million in Q3 2022 and bottomed at $13.9 million in Q3 2022.